TORNTPHARM Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > torntpharm

Technical Analysis

Technical Strength: 7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 69.3. According to RSI analysis, torntpharm is strong. 7.0 TORNTPHARM RSI Chart
MACD (?) MACD: 17.7 and Signal Line: 4.3. According to MACD analysis, torntpharm is technically strong. 8.0 TORNTPHARM MACD Chart
Simple Moving Average (?) According to simple moving average analysis, torntpharm is in a uptrend. Support level is at 1.33e+03. 9.0 TORNTPHARM Simple Moving Average Chart
Exponential Moving Average (?) 20-day exponential moving average just got above it's 50-day exponential moving average which is a positive signal. According to exponential moving average analysis, torntpharm is in a strong uptrend. Major support levels are 1329.465, 1328.038, 1325.206. 9.0 TORNTPHARM Exponential Moving Average Chart
Bollinger Bands (?) %b is 1. According to bollinger bands, torntpharm has hit the upper band which is a positive signal. 9.0 TORNTPHARM Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 1362.5984 and 1335.6. And resistance is at 1450.0. 2.0 TORNTPHARM Fibonacci Retracement Chart
Average True Range (?) ATR: 36.4 NA TORNTPHARM Average True Range Chart
Average Directional Index (?) ADX is 27.8 which means TORNTPHARM is in a trend. NA TORNTPHARM Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
April 20, 2018
Open Price 1380.05
High Price 1418.0
Low Price 1369.95
Close Price 1400.25
Absolute Change 2.1
Percentage Change 0.15%
Weekly Change 5.52%
Monthly Change 13%
Yearly Change -4.35%
52-week high 1480.0
52-week low 1141.95
Corporate Actions
ExDate Purpose
February 15, 2018 INT DIV RS 9/- PER SHARE
February 15, 2018 INTERIM DIVIDEND
June 19, 2017 DIV-RS 4 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.397
Confidence in Beta0.385%
Market Capital Rs. 23695.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 132.28
TTM Price-to-Earnings (P/E) Ratio 10.6
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 20 April 2018: Deliverable Quantity:2.41e+05 NA TORNTPHARM Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 20 April 2018: Daily Volatility:0.2732 NA TORNTPHARM Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 20 April 2018: PCR_OI:6.5 PCR:10 NA TORNTPHARM PCR Chart
Option Pain (?) 20 April 2018: Max Pain:1340.0 NA TORNTPHARM Option Pain Chart
Premium (?) 20 April 2018 Premium: -0.25 Futures OI:550500.0 NA TORNTPHARM Premium Chart
Option_MAX_OI (?) 20 April 2018: Price:1400.25 Put with maximum OI:1300.0 Call with maximum OI:1300.0 NA TORNTPHARM Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
April 26, 2018 1400.0 550500.0 627.0 639.0 1400.25
May 31, 2018 1401.1 26000.0 50.0 52.0 1400.25


April 13, 2018 Disc. under Reg.30 of SEBI (SAST) Reg.2011 Samir Mehta has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
April 12, 2018 Disc. under Reg.30 of SEBI (SAST) Reg.2011 Shaan Mehta has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 23, 2018 January 25, 2018 Raising of Funds to consider inter-alia the following: 1) Issue of Equity shares including Convertible Bonds/Debentures through Qualified Institutional Placement ( QIP) and /or Depository Receipts or any other modes. 2) Issue of Unsecured/Secured Redeemable Non-Convertible Debentures/Bonds by way of private placement.
January 23, 2018 February 08, 2018 Results/Dividend inter alia to consider and approve the Financial Results on Standalone and Consolidated basis of the Company for the quarter and nine months ended on December 31, 2017. 2) In the above meeting, the Board would also consider payment of Interim Dividend for the year 2017-18. 3) As per Regulation 42 of the Listing Regulations, the Company has fixed February 19, 2017,as the Record date for the purpose of payment of said Interim dividend, if declared by the board at their aforesaid meeting, payable to those shareholders whose name appears on the Register of Members or on records of National Securities Depositories Limited or Central Depositories Services ( India) Limited as beneficial owners as on said record date.
See all Board Meetings

TORNTPHARM is part of...

Index Weightage

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 1326 Rs. 1348 Rs. 1374 Rs. 1396 Rs. 1422 Rs. 1444 Rs. 1470